ErrorFailed to read in the CSV file.
Possible causes of error (last one being the most relevant):
No special letters (i.e. Latin, Greek) are allowed in feature names! (E,E)-17��(6-Aminohexa-1,3-dienyl)-5��-androstane-3��,14��-diol; 1,2-Bis(��-trimethylsilypropoxy)ethane; 1,2-Bis(��-trimethylsilypropoxy)ethane.1; 1,2-Bis(��-trimethylsilypropoxy)ethane.2; 1,2-Bis(��-trimethylsilypropoxy)ethane.3; 1,2-Bis(��-trimethylsilypropoxy)ethane.4; 1-(Phenylsulfonyl)-6’-isopropyl-3,4-benzo-��-carboline; 1-(��-Trimethylsilyloxyvinyl)-2-methylcyclohexene; 10,11-O-Cyclohexylidene-12-��-hydroxy-13-��-[1’-(tetrahydro-��-carbolinyl)]tetrahydrofuran; 10H-Pyrido[3,2-b][1,4]benzothiazine-10-ethanamine, N,N,��-trimethyl- (CAS); 10��-(p-Fluorophenoxy)dihydroartemisinin; 12-Methoxyabieta-8,11,13-triene-3��,19-diol; 17-Oxa-5��,13��-androstan-16-one; 2,3,3a��,4��,6,7,11b��,11c��-octahydro-9,10-dimethoxy-2-methyl–4-phenylpyrrolo[3’,4’:3,4]pyrrolo[2,1-a]isoquinoline-1,3-dione; 3,16��-Bis[[(trifluoromethyl)sulonyl]oxy]estra-1,3,5(10)-trien-17-one; 3,5-O-Cyclopentylidene-D-glycero-D-gulo-heptono-��-lactone; 3,5:6,7-Di-O-cyclopentylidene-D-glycero-D-gulo-heptono-��-lactone; 3,7-Bis[(trimethylsilyl)oxy]cholest-5-ene, (3��,7��)-; 3,7-Bis[(trimethylsilyl)oxy]cholest-5-ene, (3��,7��)-.1; 3,7��-bis(dimethylethylsilyloxy)-(heptadeuterio)cholest-5-ene; 3��,24-Di(trimethylsilyloxy)-5-cholene; 3��,24-Di(trimethylsilyloxy)-5-cholene.1; 6��,7��-dihydroxy-11,12,14-trimethoxy-abieta-8,11,13-triene; 8A��-BENZYLOXYMETHYL-7��-HYDROXY-4��-METHOXYCARBONYL-3-OXO-4A��,6,7,8A-TETRAHYDROISOCHROMANE; 9-(5-O-Benzoyl-3-ethenyl-2-deoxy-��D-erythro-pentofuranosyl)adenine; Androsta-1,4-dien-3-one, 17-methyl-17-[(trimethylsilyl)oxy]-, O-methyloxime, (17��)- (CAS); Androstan-3-one, 1,17-dimethyl-17-[(trimethylsilyl)oxy]-, O-methyloxime, (1��,5��,17��)- (CAS); Cholest-5-en-3-ol (3��)-, carbonochloridate; Cholest-5-en-3-ol (3��)-, carbonochloridate.1; Cholesta-4,6-dien-3-ol, benzoate, (3��)- (CAS); Cholestan-3-ol, (3��,5��), 1TMS; cis-N-(Benzenesulfonyl)-3-(p-methylphenyl)-2-(��-(trimethylsilyl)acetylenyl)aziridine; ethyl imino ether ��-ethoxy-��-(diethoxyphosphinyl)phenylacetaldehyde oxime; Gulonic acid, ��-lactone, 4TMS derivavative; N,O-DITOSYL-2(S)-AMINO-3-(��-INDOLYL)PROPAN-2-OL; PROSTAGLANDIN F-2 ��-TETRATMS; PROSTAGLANDIN F-2 ��-TETRATMS; Silane, [[(3��)-cholest-5-en-3-yl]oxy]trimethyl- (CAS); Silane, [[(3��)-cholest-7-en-3-yl]oxy]trimethyl- (CAS); Silane, [[(3��,24.xi.)-ergost-5-en-3-yl]oxy]trimethyl- (CAS); unknown-(3)-tetradehydroterpenediol-��-D-glucopyranoside-pentakis(trifluoroacetyl) derivative; �� AMINOISOBUTYRICACID-DITMS; ��-D-Glucopyranuronic acid, 5TMS derivative; ��-l-Galactofuranoside, methyl 6-deoxy-2,3,5-tris-O-(trimethylsilyl)- (CAS); ��-l-Galactofuranoside, methyl 6-deoxy-2,3,5-tris-O-(trimethylsilyl)- (CAS).1; ��-Linolenic acid, TMS derivative; ��-benzyl-D-glucopyranoside-tetrakis(trimethylsilyl)-ether; ��-D-Glucopyranosiduronic acid, 4-[acetyl(trimethylsilyl)amino]phenyl 2,3,4-tris-O-(trimethylsilyl)-, trimethylsilyl ester (CAS); ��-D-Glucopyranosiduronic acid, 4-[acetyl(trimethylsilyl)amino]phenyl 2,3,4-tris-O-(trimethylsilyl)-, trimethylsilyl ester (CAS).1; ��-D-Glucopyranosiduronic acid, 4-[acetyl(trimethylsilyl)amino]phenyl 2,3,4-tris-O-(trimethylsilyl)-, trimethylsilyl ester (CAS).2; ��-NITROBENZO(2,3)TRICYCLO(2.2.1.3(6,7))HEPTENE